002412.SZ
Hunan Hansen Pharmaceutical Co. Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 11.21
+10.01%Margins
Gross margin
78.1%
EBITDA margin
27.2%
EBIT margin
25.7%
Net margin
21.8%
FCF margin
16.7%
9.3%
Return on equity
8.2%
Return on assets
10.7%
Return on invested capital
0.38x
Asset turnover
CNY 185.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026